Effects of dantrolene on apoptosis and immunohistochemical expression of NeuN in the spinal cord after traumatic injury in rats

International Journal of Experimental Pathology

Volumn 91, Issue 6, 2010, Pages 530-536

  Torres, Bruno Benetti Junta ^a   Caldeira, Fátima Maria Caetano ^a   Gomes, Mardelene Geísa ^a   Serakides, Rogéria ^a   De Marco Viott, Aline ^a   Bertagnolli, Angélica Cavalheiro ^a   Fukushima, Fabíola Bono ^a   De Oliveira, Karen Maciel ^a   Gomes, Marcus Vinícius ^a   De Melo, Eliane Gonçalves ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Apoptosis; Caspase 3; Dantrolene; Immunochemistry; NeuN; Spinal cord injury; TUNEL staining

Indexed keywords

CASPASE 3; DANTROLENE; NEURON SPECIFIC NUCLEAR PROTEIN; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; LAMINECTOMY; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SPINAL CORD COMPRESSION; SPINAL CORD INJURY; SPINAL CORD NERVE CELL;

ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, NUCLEAR; APOPTOSIS; CASPASE 3; CELL COUNT; DANTROLENE; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; LAMINECTOMY; MALE; NERVE TISSUE PROTEINS; NEURONS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES;

EID: 78649517794     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2010.00738.x     Document Type: Article

References (46)

1. Allen A.R. (1911) Surgery of experimental lesion of spinal cord equivalent to crush injury of fracture dislocation of spinal column. A preliminary report. JAMA 57, 878-880.
2. Aslan A., Cemek M., Buyukokuroglu M.E. et al. (2009) Dantrolene can reduce secondary damage after spinal cord injury. Eur. Spine J. 18, 1442-1451.
3. Ayar A. & Kelestimur H. (2002) The inhibitory effects of dantrolene on action potential-induced calcium transients in cultured rat dorsal root ganglion neurons. Physiol. Res. 51, 341-346.
4. Barut S., Unlu Y.A., Karaoglan A. et al. (2005) The neuroprotective effects of z-DEVD.fmk, a caspase-3 inhibitor, on traumatic spinal cord injury in rats. Surg. Neurol. 64, 213-220.
5. Basso D.M., Beattie M.S., Bresnahan J.C. (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transaction. Exp. Neurol. 139, 244-256.
6. Beattie M.S., Farooqui A.A., Bresnahan J.C. (2000) Review of current evidence for apoptosis after spinal cord injury. J. Neurotrauma 17, 915-925.
7. Büyükokuroglu M.E. (2002) Anti-inflamatory and antinociceptive properties of dantrolene sodium in rats and mice. Pharmacol. Res. 45, 455-460.
8. Büyükokuroglu M.E., Gulçin I., Oktay M., Kufrevioglu O.I. (2001) In vitro antioxidant properties of dantrolene sodium. Pharmacol. Res. 44, 491-494.
9. Cherednichenko G., Ward C.W., Feng F. et al. (2008) Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163c is attenuated by dantrolene. Mol. Pharmacol. 73, 1203-1212.
10. Crowe M.J., Bresnahan J.C., Shuman S.L., Masters J.N., Crowe M.S. (1997) Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nat. Med. 3, 73-76.
11. Eidelberg E., Straehley D., Erspamer R., Watkins C.J. (1977) Relationship between residual hindlimb-assisted locomotion and surviving axons after incomplete spinal cord injuries. Exp. Neurol. 56, 312-322.
12. Fehlings M.G. & Tator C.H. (1995) The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury. Exp. Neurol. 132, 220-228.
13. Fehlings M.G., Tator C.H., Linden R.D. (1989) The effect of nimodipine and dextran on axonal function and blood flow following experimental spinal cord injury. J. Neurosurg. 71, 403-1416.
14. 2+ release from intracellular stores in cultured cerebral cortical neurons. J. Neurochem. 56, 1075-1078.
15. Gwak M., Park P., Kim K. et al. (2008) The effects of dantrolene on hypoxic-ischemic injury in the neonatal rat brain. Anesth. Analg. 106, 227-233.
16. 2+-accumulation in experimental spinal cord trauma. Brain Res. 211, 476-479.
17. Kobayashi S., Bannister M.L., Gangopadhyay J.P., Hamada T., Parness J., Ikemoto N. (2005) Dantrolene stabilizes domain interactions within the ryanodine receptor. J. Biol. Chem. 280, 6580-6587.
18. Kocogullari C.U., Emmiler M., Cemek M. et al. (2008) Can dantrolene protect spinal cord against ischemia/reperfusion injury? An experimental study. Thorac. Cardiovasc. Surg. 56, 406-411.
19. Krause T., Gerbershagen M.U., Fiege M., Weisshorn R., Wappler F. (2004) Dantrolene - a review of its pharmacology, therapeutic use and new developments. Anaesthesia. 59, 364-373.
20. Li F., Hayashi T., Jin G. et al. (2005) The protective effect of dantrolene on ischemic neuronal cell death is associated with reduced expression of endoplasmic reticulum stress markers. Brain Res. 1048, 59-68.
21. Liu X.Z., Xu X.M., Hu R. et al. (1997) Neuronal and glial apoptosis after traumatic spinal cord injury. J. Neurosci. 17, 5395-5406.
22. Mattson M.P. (2000) Apoptosis in neurodegenerative disorders. Nat. Rev. Mol. Cell Biol. 1, 120-129.
23. McEwen M.L. & Springer J.E. (2005) A mapping study of caspase-3 activation following acute spinal cord contusion in rats. J. Histochem. Cytochem. 53, 809-819.
24. Mori F., Okada M., Tomiyama M., Kaneko S., Wakabayashi K. (2005) Effects of ryanodine receptor activation on neurotransmitter release and neuronal cell death following kainic acid-induced status epilepticus. Epilepsy Res. 65, 59-70.
25. Muehlschlegel S. & Sims J.R. (2009) Dantrolene: mechanisms of neuroprotection and possible clinical applications in the neurointensive care unit. Neurocrit. Care. 10, 103-115.
26. Mullen R.J., Buck C.R., Smith A.M. (1992) NeuN, a neuronal specific nuclear protein in vertebrates. Development. 116, 201-211.
27. Nakayama R., Yano T., Ushijima K., Abe K., Terasaki H. (2002) Effects of dantrolene on extracellular glutamate concentration and neuronal death in the rat hippocampal CA1 region subjected to transient ischemia. Anesthesiol. 96, 705-710.
28. Negoescu A., Lorimier P., Labat-Moleur F. et al. (1996) In situ apoptotic cell labeling by the TUNEL method: improvement and evaluation on cell preparations. J. Histochem. Cytochem. 44, 959-968.
29. Orrenius S., Zhivotovsky B., Nicotera P. (2003) Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell Biol. 4, 552-565.
30. Popescu B.O., Oprica M., Sajin M. et al. (2002) Dantrolene protects neurons against kainic acid induced apoptosis in vitro and in vivo. J. Cell Mol. Med. 6, 555-569.
31. Shields L.B.E., Zhang W.P., Burke D.A., Gray R., Shields C.B. (2008) Benefit of chondroitinase abc on sensory axon regeneration in a laceration model of spinal cord injury in the rat. Surg. Neurol. 69, 568-577.
32. Solaroglu I., Kaptanoglu E., Okutan O., Beskonakli E., Attar A., Kilinc K. (2005) Magnesium sulfate treatment decreases caspase-3 activity after experimental spinal cord injury in rats. Surg. Neurol. 64, 17-21.
33. Springer J.E. (2002) Apoptotic cell death following traumatic injury to the central nervous system. J. Biochem. Mol. Biol. 35, 94-105.
34. Springer J.E., Azbill R.D., Nottingham S.A., Kennedy S.E. (2000) Calcineurin mediated BAD dephosphorylation activates the caspase-3 apoptotic cascade in traumatic spinal cord injury. J. Neurosci. 20, 7246-7251.
35. Springer J.E., Azbill R.D., Knapp P.E. (2009) Activation of the caspase-3 apoptotic cascade in traumatic spinal cord injury. Nat. Med. 5, 943-946.
36. Tagaki T., Takayasu M., Mizuno M., Yoshimoto M., Yoshida J. (2003) Caspase activation in neuronal and glial apoptosis following spinal cord injury in mice. Neurol. Med. Chir. (Tokyo) 43, 20-30.
37. Thorell W.E., Leibrock L.G., Agrawal S.K. (2002) Role of RYRs and IP3 receptors after traumatic injury to spinal cord white matter. J. Neurotrauma 19, 335-342.
38. Thuret S., Moon L.D.F., Gage F.H. (2006) Therapeutic interventions after spinal cord injury. Nat. Rev. Neurosci. 7, 628-643.
39. Uçüncü H., Taysi S., Aktan B., Buyukokuroglu M.E., Elmastas M. (2005) Effect of dantrolene on lipid peroxidation, glutathione and glutathione-dependent enzyme activities in experimental otitis media with effusion in guinea pigs. Hum. Exp. Toxicol. 24, 567-571.
40. Wei H. & Perry D.C. (1996) Dantrolene is cytoprotective in two models of neuronal cell death. J. Neurochem. 67, 2390-2398.
41. Wei H., Leeds P., Chen R.W. et al. (2000) Neuronal apoptosis induced by pharmacological concentrations of 3-hydroxykynurenine: characterization and protection by dantrolene and Bcl-2 overexpression. J. Neurochem. 75, 81-90.
42. Xu G.P., Dave K.R., Vivero R., Schmidt-Kastner R., Sick T.J., Pérez-Pinzón M.A. (2002) Improvement in neuronal survival after ischemic preconditioning in hippocampal slice cultures. Brain Res. 952, 153-158.
43. Xu G.Y., Liu S., Hughes M.G., McAdoo D.J. (2008) Glutamate-induced losses of oligodendrocytes and neurons and activation of caspase-3 in the rat spinal cord. Neurosci. 153, 1034-1047.
44. Yano T., Nakayama R., Imaizumi T., Terasaki H., Ushijima K. (2001) Dantrolene ameliorates delayed cell death and concomitant DNA fragmentation in the rat hippocampal Ca1 neurons subjected to mild ischemia. Resuscitation. 50, 117-125.
45. Zhang L., Andou Y., Masuda S., Mitani A., Kataoka K. (1993) Dantrolene protects against ischemic, delayed neuronal death in gerbil brain. Neurosci. Lett. 58, 105-108.
46. 2+ release channels. molecular mechanisms and isoform selectivity. J. Biol. Chem. 276, 13810-13816.